The 93rd National Pharmaceutical Trade Fair (PHARMCHINA) will be grandly held from October 21 to 23, 2026, at the China International Exhibition Center (Shunyi Hall) in Beijing.

NUOEN HOLDING PTE.LTD. will present a one-stop overseas expansion solution for the Southeast Asian pharmaceutical market at this grand event, joining Chinese pharmaceutical companies in exploring the tremendous opportunities in the Southeast Asian health market.

This year's pharmaceutical trade fair is held at the invitation of the Beijing Municipal Government and hosted by Reed Sinopharm Exhibitions, in conjunction with the China International Medical Equipment Fair (CMEF) and the China International Health Nutrition Expo (NHNE), with an exhibition area of 270,000 square meters. It is expected to gather more than 4,000 global exhibitors and 200,000 professional visitors, making it one of the largest and most influential annual industry events in the pharmaceutical and health sector.

Southeast Asia: A Strategic Imperative for Chinese Pharmaceutical Companies Going Global

Currently, the Southeast Asian pharmaceutical market is ushering in an unprecedented window of growth. Data shows that the pharmaceutical market of nearly 700 million people in Southeast Asia is growing at an average annual rate of 5% to 8%, significantly higher than the 2.5% to 5.5% of developed markets.Most ASEAN countries have relatively weak domestic pharmaceutical industry foundations. Indonesia relies on imports for 97% of its medicines, Thailand needs to procure 90% of its active pharmaceutical ingredients from overseas, and Malaysia, Vietnam, the Philippines, and other countries all have import drug proportions exceeding 50%.This supply-demand landscape provides vast market space for China's high-quality pharmaceutical and medical device products.

Nuoen Holding: A One-Stop Overseas Expansion Partner Deeply Rooted in Southeast Asia

Facing the fragmented pharmaceutical regulatory management systems and diversified channel ecosystems of the Southeast Asian market, Chinese pharmaceutical companies going global urgently need professional partners who understand both products and markets. Nuoen Holdings is deeply engaged in the Southeast Asian pharmaceutical market, focusing on providing comprehensive end-to-end implementation services for high-quality domestic pharmaceutical and medical device products, covering product registration, product agency, channel recruitment, and academic promotion.

The company's core team is familiar with the pharmaceutical registration regulations and market access pathways of various ASEAN countries, and has accumulated rich practical experience and channel resources in major markets such as Indonesia, Malaysia, Thailand, Vietnam, and the Philippines. We understand that true overseas expansion is not simply "product export," but a systematic project from registration compliance to market penetration. Nuoen Holdings is committed to helping Chinese pharmaceutical companies overcome information barriers and resource gaps, achieving the critical leap from "going out" to "getting in."

Meet in Beijing, Embark Together on a New Journey in Southeast Asia

During this year's pharmaceutical trade fair, the Nuoen Holdings team will engage in in-depth exchanges with representatives of domestic pharmaceutical companies on-site, sharing the real demands, registration key points, and channel strategies of pharmaceutical markets in various Southeast Asian countries, and providing customized overseas expansion recommendations based on the product characteristics of different companies.

Welcome to visit the Nuoen Holdings booth to discuss cooperation.

Exhibition Dates: October 21-23, 2026

Exhibition Venue: China International Exhibition Center (Shunyi Hall), Beijing

The dividends of the Southeast Asian health market are being released at an accelerating pace. Nuoen Holdings looks forward to joining hands with more high-quality Chinese pharmaceutical companies, using professional capabilities and local resources as leverage to jointly unlock this emerging market full of potential, so that good products can find good markets and the path to going global can be walked more steadily and further.